Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fegan

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|August 28, 1998
Parenteral glutamine protects hepatic function during bone marrow transplantationS A Brown, A Goringe, C Fegan, et al.
Leukemia|February 9, 2007
Highly purified CD38+ and CD38- sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal originC Pepper, R Ward, T T Lin, et al.
Leukemia|October 29, 2014
Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibitionC Pepper, A G S Buggins, C H Jones, et al.
Leukemia|October 12, 2011
Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stageB Britt-Compton, T T Lin, G Ahmed, et al.
Leukemia|January 31, 2015
Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 studyV Goede, K Fischer, A Engelke, et al.
British Journal of Cancer|October 5, 2013
p53 and cell cycle independent dysregulation of autophagy in chronic lymphocytic leukaemiaM J Groves, C E Johnson, J James, et al.
Leukemia|February 21, 2017
Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLLT Munir, D R Howard, L McParland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphomaS Rao, D Watkins, D Cunningham, et al.
Cell Proliferation|June 8, 2011
Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2C Pepper, J G Mahdi, A G S Buggins, et al.
Nature Communications|November 20, 2024
Saturation of the compression of two interacting magnetized plasma toroids evidenced in the laboratoryA Sladkov, C Fegan, W Yao, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|August 28, 1998
Parenteral glutamine protects hepatic function during bone marrow transplantationS A Brown, A Goringe, C Fegan, et al.
Leukemia|February 9, 2007
Highly purified CD38+ and CD38- sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal originC Pepper, R Ward, T T Lin, et al.
Leukemia|October 29, 2014
Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibitionC Pepper, A G S Buggins, C H Jones, et al.
Leukemia|October 12, 2011
Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stageB Britt-Compton, T T Lin, G Ahmed, et al.
Leukemia|January 31, 2015
Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 studyV Goede, K Fischer, A Engelke, et al.
British Journal of Cancer|October 5, 2013
p53 and cell cycle independent dysregulation of autophagy in chronic lymphocytic leukaemiaM J Groves, C E Johnson, J James, et al.
Leukemia|February 21, 2017
Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLLT Munir, D R Howard, L McParland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphomaS Rao, D Watkins, D Cunningham, et al.
Cell Proliferation|June 8, 2011
Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2C Pepper, J G Mahdi, A G S Buggins, et al.
Nature Communications|November 20, 2024
Saturation of the compression of two interacting magnetized plasma toroids evidenced in the laboratoryA Sladkov, C Fegan, W Yao, et al.
Pageof 5